Abstract

Splenic artery aneurysm (SAA) is the most common visceral artery aneurysm, with a reported prevalence of 0.8% on arteriography and 0.04–0.10% at autopsy (1). Abbas et al . (2) reported that asymptomatic SAAs of >2 cm in size have an increased risk of rupture. SAAs are both more frequent and larger in adults with chronic liver disease and portal hypertension (3), and SAA rupture is associated with a higher mortality rate in patients with portal hypertension than in other patients (3). Percutaneous transcatheter embolization of SAAs with coils is widely accepted as the first line of treatment because it is safe, has a low mortality rate, and provides adequate short- and long-term results (4).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.